General MedicationsORALGeneric
CLARITHROMYCIN
CLARITHROMYCIN
Standard Dose
125MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview CLARITHROMYCIN is listed in Drugs@FDA under application 065382 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient CLARITHROMYCIN Form and strength FOR SUSPENSION;ORAL - 125MG/5ML Sponsor SUN PHARM INDS LTD Submission history Latest submission status date: 2013-07-11 00:00:00.
Structured Monograph
Clinical summary
Approval overview CLARITHROMYCIN is listed in Drugs@FDA under application 065382 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CLARITHROMYCIN Form and strength FOR SUSPENSION;ORAL - 125MG/5ML Sponsor SUN PHARM INDS LTD Submission history Latest submission status date: 2013-07-11 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.